Strides Arcolab has reported results for first quarter ended March 31, 2013.
The company has reported a net profit of Rs 31.57 crore for the quarter ended March 31, 2013 as compared to a net loss of Rs 28.16 crore for the same quarter in the previous year. Total income from operation of the company has increased by 33.49% at Rs 195.05 crore for quarter under review as compared to Rs 146.12 crore for the quarter ended March 31, 2012.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
